This company has shut down. Gyroscope Therapeutics is no longer operating — its last tracked round was a Corporate Round in 2021.
Explore the Startup GraveyardGyroscope Therapeutics is a clinical-stage gene therapy company focused on developing therapies and treating diseases of the eye.
Gyroscope Therapeutics has raised $60.0M in total funding. The most recent round was Corporate Round. The last funding was announced in November 2021.
Gyroscope Therapeutics's investors include Sanofi, Sofinnova Investments, Forbion Capital Partners, Cambridge Innovation Capital, Fosun Pharma.
Gyroscope Therapeutics is headquartered in Stevenage, United Kingdom.
Gyroscope Therapeutics is a clinical-stage gene therapy company focused on developing therapies and treating diseases of the eye.
Gyroscope Therapeutics is at the Corporate Round stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Gyroscope Therapeutics — Funding & Investors." VCBacked, November 8, 2021, https://www.vcbacked.co/company/gyroscope-therapeutics. Accessed August 15, 2026.
VCBacked. (2021). Gyroscope Therapeutics — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/gyroscope-therapeutics
{{cite web |title=Gyroscope Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/gyroscope-therapeutics |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated